GPX3 and breast carcinoma: In summary, our current findings indicate that GPX3 is markedly downregulated in breast cancer, promotes in vitro growth and metastasis of breast cancer cells, and servers as a promising diagnostic or prognostic biomarker for patients with breast cancer.